106 related articles for article (PubMed ID: 16263278)
1. Novel phenylamino acetamide derivatives as potent and selective kappa opioid receptor agonists.
Chu GH; Gu M; Cassel JA; Belanger S; Stabley GJ; DeHaven RN; Conway-James N; Koblish M; Little PJ; DeHaven-Hudkins DL; Dolle RE
Bioorg Med Chem Lett; 2006 Feb; 16(3):645-8. PubMed ID: 16263278
[TBL] [Abstract][Full Text] [Related]
2. Potent and highly selective kappa opioid receptor agonists incorporating chroman- and 2,3-dihydrobenzofuran-based constraints.
Chu GH; Gu M; Cassel JA; Belanger S; Graczyk TM; DeHaven RN; Conway-James N; Koblish M; Little PJ; DeHaven-Hudkins DL; Dolle RE
Bioorg Med Chem Lett; 2005 Dec; 15(23):5114-9. PubMed ID: 16203140
[TBL] [Abstract][Full Text] [Related]
3. The peripherally acting kappa-opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivity.
Gottschlich R; Barber A; Bartoszyk GD; Seyfried CA
Drugs Exp Clin Res; 1995; 21(5):171-4. PubMed ID: 8846746
[TBL] [Abstract][Full Text] [Related]
4. Arylacetamides as peripherally restricted kappa opioid receptor agonists.
Kumar V; Marella MA; Cortes-Burgos L; Chang AC; Cassel JA; Daubert JD; DeHaven RN; DeHaven-Hudkins DL; Gottshall SL; Mansson E; Maycock AL
Bioorg Med Chem Lett; 2000 Nov; 10(22):2567-70. PubMed ID: 11086731
[TBL] [Abstract][Full Text] [Related]
5. Isolation and chemical modification of clerodane diterpenoids from Salvia species as potential agonists at the kappa-opioid receptor.
Li Y; Husbands SM; Mahon MF; Traynor JR; Rowan MG
Chem Biodivers; 2007 Jul; 4(7):1586-93. PubMed ID: 17638340
[TBL] [Abstract][Full Text] [Related]
6. Amino acid conjugates as kappa opioid receptor agonists.
Kumar V; Guo D; Daubert JD; Cassel JA; DeHaven RN; Mansson E; DeHaven-Hudkins DL; Maycock AL
Bioorg Med Chem Lett; 2005 Mar; 15(5):1279-82. PubMed ID: 15713370
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.
Kumar V; Guo D; Cassel JA; Daubert JD; Dehaven RN; Dehaven-Hudkins DL; Gauntner EK; Gottshall SL; Greiner SL; Koblish M; Little PJ; Mansson E; Maycock AL
Bioorg Med Chem Lett; 2005 Feb; 15(4):1091-5. PubMed ID: 15686919
[TBL] [Abstract][Full Text] [Related]
8. kappa-Opioid activity of the four stereoisomers of the peripherally selective kappa-agonists, EMD 60,400 and EMD 61,753.
Gottschlich R; Krug M; Barber A; Devant RM
Chirality; 1994; 6(8):685-9. PubMed ID: 7857777
[TBL] [Abstract][Full Text] [Related]
9. Use of receptor chimeras to identify small molecules with high affinity for the dynorphin A binding domain of the kappa opioid receptor.
Kumar V; Guo D; Marella M; Cassel JA; Dehaven RN; Daubert JD; Mansson E
Bioorg Med Chem Lett; 2008 Jun; 18(12):3667-71. PubMed ID: 18487043
[TBL] [Abstract][Full Text] [Related]
10. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
11. The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons.
Su X; Castle NA; Antonio B; Roeloffs R; Thomas JB; Krafte DS; Chapman ML
Anesth Analg; 2009 Aug; 109(2):632-40. PubMed ID: 19608841
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR study of opioid receptor ligands: mono- and bis-indolomorphinans.
Li F; Yin C; Chen J; Liu J; Xie X; Zhang A
Chem Biol Drug Des; 2009 Oct; 74(4):335-42. PubMed ID: 19691470
[TBL] [Abstract][Full Text] [Related]
13. [Opioid receptors and their selective ligands].
Piestrzeniewicz MK; Fichna J; Janecka A
Postepy Biochem; 2006; 52(3):313-9. PubMed ID: 17201067
[TBL] [Abstract][Full Text] [Related]
14. Establishment of kappa opioid receptor agonists pharmacophore with molecular modeling method.
Liu DX; Tang Y; Jiang HL; Chen KX; Ji RY
Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):445-50. PubMed ID: 10375807
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of pyrrolomorphinan derivatives as kappa opioid agonists.
Fujii H; Ida Y; Hanamura S; Osa Y; Nemoto T; Nakajima M; Hasebe K; Nakao K; Mochizuki H; Nagase H
Bioorg Med Chem Lett; 2010 Sep; 20(17):5035-8. PubMed ID: 20685120
[TBL] [Abstract][Full Text] [Related]
16. Novel malonamide derivatives as potent kappa opioid receptor agonists.
Chu GH; Gu M; Cassel JA; Belanger S; Graczyk TM; DeHaven RN; Conway-James N; Koblish M; Little PJ; DeHaven-Hudkins DL; Dolle RE
Bioorg Med Chem Lett; 2007 Apr; 17(7):1951-5. PubMed ID: 17307360
[TBL] [Abstract][Full Text] [Related]
17. Chemical function-based pharmacophore development for novel, selective kappa opioid receptor agonists.
Singh N; Nolan TL; McCurdy CR
J Mol Graph Model; 2008 Sep; 27(2):131-9. PubMed ID: 18456526
[TBL] [Abstract][Full Text] [Related]
18. N,N-dialkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, potent, selective delta opioid agonists.
Carson JR; Coats SJ; Codd EE; Dax SL; Lee J; Martinez RP; Neilson LA; Pitis PM; Zhang SP
Bioorg Med Chem Lett; 2004 May; 14(9):2109-12. PubMed ID: 15080989
[TBL] [Abstract][Full Text] [Related]
19. 3-Pyrroline containing arylacetamides: a novel series of remarkably selective kappa-agonists.
Mou QY; Chen J; Zhu YC; Zhou DH; Chi ZQ; Long YQ
Bioorg Med Chem Lett; 2002 Sep; 12(17):2287-90. PubMed ID: 12161117
[TBL] [Abstract][Full Text] [Related]
20. N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands.
Rivara S; Vacondio F; Fioni A; Silva C; Carmi C; Mor M; Lucini V; Pannacci M; Caronno A; Scaglione F; Gobbi G; Spadoni G; Bedini A; Orlando P; Lucarini S; Tarzia G
ChemMedChem; 2009 Oct; 4(10):1746-55. PubMed ID: 19728346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
